Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc (CNTA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CNTA · as of Jun 8, 2026
Key Statistics
Explore Centessa Pharmaceuticals plc Data
cnta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 14 · Buy rate: 57.1%
The CNTA analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month price target is $39.50, representing -0.30% downside from the current price of $39.62.
Competitors & Peers
cnta competitorsCNTA
AAPG
APGE
CELC
CGON
DYNStock Performance
Full HistoryAbout Centessa Pharmaceuticals plc
Centessa Pharmaceuticals plc a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V…
what is centessa pharmaceuticals plc · cnta stock overview · centessa pharmaceuticals plc company profile · who is centessa pharmaceuticals plc ceo · cnta NASDAQ · centessa pharmaceuticals plc headquarters · centessa pharmaceuticals plc business segments
About Stock Overview & Key Data
Centessa Pharmaceuticals plc (CNTA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 28, 2021. As of the latest trading session, CNTA stock price is $39.62, with a market capitalization of $6.1B. The stock has returned +231.83% over the past 12 months and +58.42% year-to-date.
According to 14 Wall Street analysts, the consensus rating for Centessa Pharmaceuticals plc stock is Buy, with an average 12-month price target of $39.50. In fiscal year 2025, Centessa Pharmaceuticals plc reported revenue of $15.0M and net income of -$197.5M. For detailed data — including Centessa Pharmaceuticals plc revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Centessa Pharmaceuticals plc (CNTA) stock price is $39.62. The stock is traded on NASDAQ under the ticker symbol CNTA. The 52-week range is $10.95 – $40.26.